M

Myeloid Therapeutics

40 employees

Myeloid Therapeutics is a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Life Science

Date founded

2019

Funding rounds raised

Total raised

$73M

from 3 investors over 3 rounds

M

Myeloid Therapeutics raised $73M on May 18, 2023

Investors: Newpath Partners, ARCH Venture Partners and 8VC

FAQ